Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
2,688,809
-
Share change
-
-209,312
-
Total reported value
-
$3,664,000
-
Price per share
-
$1.40
-
Number of holders
-
11
-
Value change
-
-$283,788
-
Number of buys
-
5
-
Number of sells
-
6
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q4 2016
As of 31 Dec 2016,
Aptose Biosciences Inc. - Common Shares was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,688,809 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, Cormorant Asset Management, LLC, BAKER BROS. ADVISORS LP, BANK OF MONTREAL /CAN/, ROYAL BANK OF CANADA, TWO SIGMA SECURITIES, LLC, JANE STREET GROUP, LLC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, and UBS Group AG.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.